Whitefort Capital Management, LP — 13F Holdings & Portfolio
CIK 1884931 · latest 13F-HR filed 2026-05-15
Whitefort Capital Management, LP manages $339.1M in 13F-reported U.S. long-equity assets across 20 reported positions as of its 2026-03-31 13F-HR filing. Its largest disclosed positions are ABUS (19.81%), ROIV (11.59%), JOYY (9.04%). Quarter over quarter (versus its 2025-12-31 filing) the fund opened 3 new positions, exited 1, added to 6, and trimmed 8.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
$339.1M
Long-equity book
20
Distinct positions
2026-03-31
Filed 2026-05-15
+3 / −1 / ↑6 / ↓8
vs 2025-12-31
| Name | Title / Status | Ownership | Type |
|---|
Top Adds (vs prior quarter)
- SABLE OFFSHORE CORP$8.3M +48.1%
- JOYY INC$4.4M +16.9%
- GENWORTH FINL INC$2.5M +10.8%
- SURGERY PARTNERS INC$1.6M +17.2%
- INNOVATE CORP$861.9K +25.7%
Top Trims
- BALLYS CORPORATION-$8.5M -26.9%
- ROIVANT SCIENCES LTD-$6.7M -14.6%
- OMNIAB INC-$4.0M -15.1%
- CADIZ INC-$2.8M -12.5%
- USA TODAY CO INC-$2.6M -10.4%
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | ARBUTUS BIOPHARMA CORP | ABUS | 03879J100 | $67.2M | 19.81% | 14,930,885 | SH |
| 2 | ROIVANT SCIENCES LTD | ROIV | G76279101 | $39.3M | 11.59% | 1,419,000 | SH |
| 3 | JOYY INC | JOYY | 46591M109 | $30.7M | 9.04% | 524,944 | SH |
| 4 | SABLE OFFSHORE CORP | SOC | 78574H104 | $25.5M | 7.53% | 1,544,793 | SH |
| 5 | GENWORTH FINL INC | GNW | 37247D106 | $25.4M | 7.50% | 3,130,301 | SH |
| 6 | BALLYS CORPORATION | BALY | 05875B304 | $23.2M | 6.85% | 2,408,063 | SH |
| 7 | OMNIAB INC | OABI | 68218J103 | $22.3M | 6.59% | 14,223,658 | SH |
| 8 | USA TODAY CO INC | TDAY | 36472T109 | $22.0M | 6.50% | 3,124,833 | SH |
| 9 | CADIZ INC | CDZI | 127537207 | $19.6M | 5.77% | 3,986,822 | SH |
| 10 | OPKO HEALTH INC | OPK | 68375NAG8 | $11.6M | 3.43% | 9,350,000 | PRN |
| 11 | SURGERY PARTNERS INC | SGRY | 86881A100 | $10.9M | 3.20% | 911,136 | SH |
| 12 | UNIQURE NV | QURE | N90064101 | $10.8M | 3.17% | 657,611 | SH |
| 13 | SPDR GOLD TR Call | GLD | 78463V107 | $10.5M | 3.10% | 24,400 | SH |
| 14 | PUBMATIC INC | PUBM | 74467Q103 | $5.6M | 1.66% | 690,000 | SH |
| 15 | OPKO HEALTH INC | OPK | 68375N103 | $4.8M | 1.43% | 4,253,340 | SH |
| 16 | INNOVATE CORP | VATE | 45784J303 | $4.2M | 1.24% | 743,000 | SH |
| 17 | TEADS HLDG CO | TEAD | 69002R103 | $2.4M | 0.70% | 3,610,103 | SH |
| 18 | KESTREL GROUP LTD | KG | G5260K102 | $1.7M | 0.51% | 160,916 | SH |
| 19 | NEXTNAV INC | NN | 65345N106 | $971.7K | 0.29% | 60,655 | SH |
| 20 | NEXTNAV INC | NNAVW | 65345N114 | $299.2K | 0.09% | 47,264 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-03-31 | 2026-05-15 | $339.1M | 20 | 0001013594-26-000606 |
| 2025-12-31 | 2026-02-17 | $391.2M | 20 | 0001013594-26-000254 |
| 2025-09-30 | 2025-11-14 | $338.3M | 18 | 0001013594-25-001427 |